Jeremy Richard Rush

Title: Jeremy Richard Rush: Innovator in Vaccine Composition Quantification

Introduction

Jeremy Richard Rush is a notable inventor based in Liberty, MO (US). He has made significant contributions to the field of vaccine development, particularly in the quantification of viral proteins. With a total of 2 patents, his work has implications for improving vaccine efficacy and safety.

Latest Patents

One of his latest patents is focused on the "Quantification of vaccine compositions." This invention provides methods and mass-labeled peptides for quantifying the presence of one or more viral proteins in a sample of a preparation containing agents that bind to said viral protein. The methods utilize mass-spectroscopic analyses of the sample and standards containing known amounts of labeled and unlabeled signature peptides. Specifically, the viral proteins targeted in this invention are antigens in a vaccine for porcine circovirus.

Career Highlights

Throughout his career, Jeremy has worked with prominent companies in the veterinary health sector. He has been associated with Boehringer Ingelheim Vetmedica GmbH and Boehringer Ingelheim Animal Health USA Inc. His experience in these organizations has allowed him to contribute to advancements in animal health and vaccine development.

Collaborations

Jeremy has collaborated with several professionals in his field, including Marc Allan Eichmeyer and Michael B Roof. These collaborations have further enriched his work and expanded the impact of his inventions.

Conclusion

Jeremy Richard Rush is a dedicated inventor whose work in vaccine composition quantification is paving the way for advancements in veterinary medicine. His contributions are vital for enhancing the effectiveness of vaccines, particularly in combating viral infections in animals.